Miller-Fisher Syndrome Following Influenza A Infection.
guillain-barre syndrome (gbs)
influenza virus type a
intravenous immunoglobulins (ivig)
methyl prednisolone
miller fisher syndrome (mfs)
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
Mar 2024
Mar 2024
Historique:
accepted:
12
03
2024
medline:
15
4
2024
pubmed:
15
4
2024
entrez:
15
4
2024
Statut:
epublish
Résumé
Miller-Fisher syndrome (MFS), characterized by ophthalmoplegia, ataxia, and areflexia, is a Guillain-Barré syndrome (GBS) variant. It is well-known that the causative antibody for MFS is anti-GQ1b antibody. This report describes a rare case of MFS with not only anti-GQ1b antibodies but also anti-GT1a antibodies following Influenza A infection. The patient, a 47-year-old woman, contracted Influenza A three weeks before admission. She complained of double vision followed by areflexia, ataxia in the four extremities, and complete gaze palsy. She was treated with intravenous methylprednisolone pulse and intravenous immunoglobulin therapies. Her neurological symptoms were recovered after these immunotherapies.
Identifiants
pubmed: 38618457
doi: 10.7759/cureus.56064
pmc: PMC11009552
doi:
Types de publication
Case Reports
Langues
eng
Pagination
e56064Informations de copyright
Copyright © 2024, Mitsuhashi et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.